Status:
TERMINATED
Pilot Study of BOTOX for Migraine Headaches
Lead Sponsor:
HealthPartners Institute
Collaborating Sponsors:
Allergan
Conditions:
Migraine Headache
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purposes of this study are to assess whether subjects treated with BOTOX will: 1. have a decrease in the frequency and intensity of migraine headaches 2. experience improvements in quality of lif...
Eligibility Criteria
Inclusion
- Subjects \> 18 years of age
- Subject has an established history of migraine headache, with or without aura, per IHS criteria (1.2.1 or 1.1), for at least 6 months prior to screening.
- Subject receives primary health care from Park Nicollet Health Services.
Exclusion
- Subject has received previous injections of botulinum toxin of any serotype for any reason, within the 6 months prior to study participation.
- Additional eligibility will be discussed at point of contact
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2010
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00850421
Start Date
April 1 2004
End Date
April 1 2010
Last Update
September 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Park Nicollet Health Services
Minneapolis, Minnesota, United States, 55426